Your browser doesn't support javascript.
loading
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008-2015): A cross-national drug utilization study.
Ibáñez, Luisa; Sabaté, Mònica; Vidal, Xavier; Ballarin, Elena; Rottenkolber, Marietta; Schmiedl, Sven; Heeke, Andreas; Huerta, Consuelo; Martin Merino, Elisa; Montero, Dolores; Leon-Muñoz, Luz María; Gasse, Christiane; Moore, Nicholas; Droz, Cécile; Lassalle, Régis; Aakjaer, Mia; Andersen, Morten; De Bruin, Marie Louise; Groenwold, Rolf; van den Ham, Hendrika A; Souverein, Patrick; Klungel, Olaf; Gardarsdottir, Helga.
Afiliación
  • Ibáñez L; Fundació Institut Català de Farmacologia (FICF), Hospital Vall d'Hebron, Barcelona, Spain.
  • Sabaté M; Department of Clinical Pharmacology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Vidal X; Department of Pharmacology, Toxicology and Therapeutics, Universitat Autònoma de Barcelona, Spain.
  • Ballarin E; Fundació Institut Català de Farmacologia (FICF), Hospital Vall d'Hebron, Barcelona, Spain.
  • Rottenkolber M; Department of Clinical Pharmacology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Schmiedl S; Department of Pharmacology, Toxicology and Therapeutics, Universitat Autònoma de Barcelona, Spain.
  • Heeke A; Fundació Institut Català de Farmacologia (FICF), Hospital Vall d'Hebron, Barcelona, Spain.
  • Huerta C; Department of Clinical Pharmacology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Martin Merino E; Department of Pharmacology, Toxicology and Therapeutics, Universitat Autònoma de Barcelona, Spain.
  • Montero D; Fundació Institut Català de Farmacologia (FICF), Hospital Vall d'Hebron, Barcelona, Spain.
  • Leon-Muñoz LM; Department of Clinical Pharmacology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Gasse C; Diabetes Research Group, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany.
  • Moore N; Department of Clinical Pharmacology, School of Medicine, Faculty of Health, Witten/Herdecke University, Witten, Germany.
  • Droz C; Philipp Klee-Institute for Clinical Pharmacology, Helios University Hospital Wuppertal, Wuppertal, Germany.
  • Lassalle R; AOK NORDWEST, Dortmund, Germany.
  • Aakjaer M; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain.
  • Andersen M; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain.
  • De Bruin ML; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain.
  • Groenwold R; Pharmacoepidemiology and Pharmacovigilance Division, Spanish Agency of Medicines and Medical Devices (AEMPS), Madrid, Spain.
  • van den Ham HA; Aarhus University, Aarhus C, Denmark.
  • Souverein P; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, CHU de Bordeaux, Bordeaux, France.
  • Klungel O; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, CHU de Bordeaux, Bordeaux, France.
  • Gardarsdottir H; Bordeaux PharmacoEpi, INSERM CIC1401, Université de Bordeaux, CHU de Bordeaux, Bordeaux, France.
Br J Clin Pharmacol ; 85(11): 2524-2539, 2019 11.
Article en En | MEDLINE | ID: mdl-31318059
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Utilización de Medicamentos / Anticoagulantes Tipo de estudio: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 País/Región como asunto: Europa Idioma: En Revista: Br J Clin Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Utilización de Medicamentos / Anticoagulantes Tipo de estudio: Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 País/Región como asunto: Europa Idioma: En Revista: Br J Clin Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: España Pais de publicación: Reino Unido